University Hospital Tuebingen
623
94
110
298
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
7.5%
47 terminated/withdrawn out of 623 trials
86.4%
-0.2% vs industry average
9%
53 trials in Phase 3/4
3%
10 of 298 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (623)
Evaluation of Low-thermal Argon Plasma Devitalization for the Treatment of CIN 2 Versus Standard of Active Surveillance
Role: lead
DEfeating PEnile CAncer-2
Role: lead
Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma
Role: lead
SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabetes
Role: lead
Peptide Vaccine for Fibrolamellar Hepatocellular Carcinoma Patients and Other Tumor Entities Carrying the Driver Fusion DNAJB1-PRKACA
Role: lead
Transcutaneous Vagus Nerve Stimulation (tVNS) for Improved Recovery After Exertion.
Role: lead
Non-Interventional Study on the Prevalence of Cardiac Amyloidosis in Patients With Higher-Grade Aortic Valve Stenosis - Evaluation Using Echocardiography, Computed Tomography, Tc99-SPECT/CT and Cardiac Magnetic Resonance Imaging (CMR)
Role: lead
ARTEMIS - The ARTEMIS Cohort
Role: collaborator
A Strong Start in Life - ELAS 2.0: A Digital Learning Program to Promote a Healthy Pregnancy and Early Child Protection
Role: lead
Effectiveness of an E-Learning Training on Addressing Alcohol Use During Pregnancy
Role: lead
Brain Signal Training to Enhance Affect Down-regulation
Role: collaborator
Cerebellar Mutism Syndrome Study
Role: collaborator
Children of Mentally Ill Parents-Network - CHIMPS-NET
Role: collaborator
The Effect of Physiotherapy Integrated With Yoga and Mindfulness on Individuals With Fibromyalgia
Role: lead
Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease
Role: lead
Tübinger Diabetes Mellitus Database (TUEDID)
Role: lead
Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants
Role: lead
A Study to Assess the Safety and Immunogenicity of a COVID-19 Vaccine Booster in Healthy Adults
Role: lead
Patients With Metastasized Prostate Cancer Whose Prostate-specific Antigen-level (PSA) Remains >0,2 ng/ml After Six Months of Dual Antihormonal Therapy Will Receive Radiotherapy to the Prostate and Radiotherapy to Refractory Metastases
Role: lead
E-health-supported Diagnostic and Intervention in Preterm Born Children and Their Families
Role: lead